MedTrace Logo

A Clinical Study of SHR-A1811(sc) Subcutaneous Injection in Patients With Solid Tumor

NCT07275242 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 107

Last updated 2026-01-15

No results posted yet for this study

Summary

The study is being conducted to evaluate the pharmacokinetics , safety, tolerability and efficacy in patients with solid tumor.

Conditions

Interventions

DRUG

SHR-A1811 Subcutaneous Injection

SHR-A1811 subcutaneous injection.

DRUG

SHR-A1811 for Injection

SHR-A1811 for injection.

Sponsors & Collaborators

  • Suzhou Suncadia Biopharmaceuticals Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-23
Primary Completion
2027-06-30
Completion
2027-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07275242 on ClinicalTrials.gov